市場調査レポート
商品コード
1450944
脳深部刺激療法市場レポート:刺激タイプ、製品、用途、エンドユーザー、地域別2024-2032Deep Brain Stimulation Market Report by Stimulation Type, Product, Application (Parkinson's Disease, Epilepsy, Dystonia, Obsessive Compulsive Disorder, and Others), End-User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
脳深部刺激療法市場レポート:刺激タイプ、製品、用途、エンドユーザー、地域別2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界の脳深部刺激療法市場規模は2023年に13億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに26億米ドルに達し、2024年から2032年の間に8.3%の成長率(CAGR)を示すと予測しています。大衆の間でさまざまな運動障害や神経障害の発生が増加していること、低侵襲(MI)手術法が受け入れられつつあること、世界中で病院、介護施設、診療所が建設されていることなどが、市場を牽引する主な要因となっています。
脳深部刺激療法(DBS)とは、パーキンソン病、てんかん、ジストニア、強迫性障害(OCD)など、さまざまな神経疾患や運動関連疾患の治療に役立つ外科手術を指します。これは、脳の特定の領域に電極を埋め込み、脳内の異常なインパルスを調整するための電気インパルスを発生させるものです。この治療法は、プログラマブル・ジェネレーターと呼ばれるペースメーカーのような装置を患者の胸部上部の皮下に埋め込み、その装置と電極をつなぐワイヤーを使用します。これは、インパルスを引き起こす神経機能障害の形成をブロックし、脳が効果的に機能するのを助ける。高用量の薬物に全面的に依存することなく、患者が振戦、こわばり、ジスキネジアに対処するのを助ける。トゥレット症候群、ハンチントン病、コレア、群発頭痛、慢性疼痛の治療に用いられます。また、患者が良好なQOLを維持するために、薬物療法が有効でなくなった場合にも利用されます。さらに、DBSは制御された方法で脳の活動を直接変化させるため、世界中の神経外科医、神経科医、神経心理学者、精神科医に推奨されています。
現在、大衆の間でさまざまな運動障害や神経障害の発生が増加しているため、DBSに対する需要が増加しており、これが市場にプラスの影響を与える主な要因の1つとなっています。これに加えて、術後の傷跡を減らし、医療費を最小限に抑え、入院期間を短縮するための低侵襲(MI)手術法が受け入れられつつあることも、良好な市場見通しをもたらしています。さらに、世界中の患者に質の高いヘルスケアサービスを提供するために、病院、老人ホーム、クリニックの建設が増加しています。これに加えて、さまざまな神経疾患や精神疾患の治療と診断の改善における進歩の数が増加していることも、市場の成長を後押ししています。これとは別に、DBSの利点と神経学的合併症の早期発見に関する認知度の向上が、世界の老人人口の増加とともに市場の成長を支えています。また、働き盛りの人々の間で、さまざまな生活習慣病や高血圧に起因するうつ病の発生が増加していることも、市場の成長を強化しています。さらに、主要な市場参入企業は、ロボット支援植え込みと多標的刺激を実現するために、DBSシステムに人工知能(AI)とモノのインターネット(IoT)を組み込んでいます。
The global deep brain stimulation market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of the key factors driving the market.
Deep brain stimulation (DBS) refers to the surgical procedure that aids in treating various neurological and movement-associated disorders, such as Parkinson's disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves implanting electrodes within certain areas of the brain to produce electrical impulses for regulating abnormal impulses in the brain. It relies on a pacemaker-like device, called a programmable generator, placed under the skin of the upper chest of the patient along with a wire that connects the device to the electrodes. It blocks the formation of neurological dysfunction, causing impulses, and aids the brain in functioning effectively. It helps patients handle tremors, stiffness, and dyskinesias without fully relying on high doses of medications. It is employed in the treatment of Tourette syndrome, Huntington's disease, chorea, cluster headaches, and chronic pain. It is also utilized when medications are no longer effective for patients in maintaining a good quality of life. Furthermore, as DBS directly alters brain activity in a controlled manner, it is recommended by neurosurgeons, neurologists, neuropsychologists, and psychiatrists around the world.
At present, the increasing demand for DBS due to the rising occurrence of various motor and neurological disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing acceptance of minimally invasive (MI) surgical methods to reduce post-operative scarring, minimize the cost of medical bills, and decrease the duration of hospital stays is offering a favorable market outlook. Additionally, there is an increase in the construction of hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe. This, along with the rising number of advancements made in improving the treatment and diagnosis of various neurological and psychological disorders, is propelling the growth of the market. Apart from this, the increasing awareness about the benefits of DBS and early detection of neurological complications, along with the rising geriatric population worldwide, is supporting the growth of the market. In addition, the rising occurrence of various lifestyle disorders and hypertension-induced depression among working individuals is strengthening the market growth. Moreover, key market players are incorporating artificial intelligence (AI) and the internet of things (IoT) in DBS systems to create robot-assisted implantations and multitarget stimulations.
IMARC Group provides an analysis of the key trends in each segment of the global deep brain stimulation market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on stimulation type, product, application, and end-user.
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
The report has provided a detailed breakup and analysis of the deep brain stimulation market based on the stimulation type. This includes subthalamic DBS, globus pallidus DBS, thalamic DBS, and pedunculopontine nucleus DBS.
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
A detailed breakup and analysis of the deep brain stimulation market based on the product has also been provided in the report. This includes single channel deep brain stimulator and dual channel deep brain stimulator. According to the report, dual channel deep brain stimulator accounted for the largest market share.
Parkinson's Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
A detailed breakup and analysis of the deep brain stimulation market based on the application has also been provided in the report. This includes Parkinson's disease (PD), epilepsy, dystonia, obsessive compulsive disorder (OCD), and others. According to the report, Parkinson's disease (PD) accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
A detailed breakup and analysis of the deep brain stimulation market based on the end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, neurological centers, and others. According to the report, hospitals accounted for the largest market share.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for deep brain stimulation. Some of the factors driving the North America deep brain stimulation market included the growing investment in the medical sector, rising construction of healthcare facilities, increasing occurrence of various neurological conditions among the masses, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global deep brain stimulation market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace, Neuro Sigma, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.